Literature DB >> 17990240

Cost-effectiveness of herpes zoster vaccine: flawed assumptions regarding efficacy against postherpetic neuralgia.

Marc Brisson, James M Pellissier, Myron J Levin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17990240     DOI： 10.1086/523011

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  9 in total

Review 1.  Cost-effectiveness of vaccination against herpes zoster.

Authors:  Pieter T de Boer; Jan C Wilschut; Maarten J Postma
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Herpes zoster and postherpetic neuralgia surveillance using structured electronic data.

Authors:  Michael Klompas; Martin Kulldorff; Yury Vilk; Stephanie R Bialek; Rafael Harpaz
Journal:  Mayo Clin Proc       Date:  2011-10-13       Impact factor: 7.616

3.  Acute herpes zoster and post herpetic neuralgia in primary care: a study of diagnosis, treatment and cost.

Authors:  Brendan Crosbie; Sinead Lucey; Lesley Tilson; Lisa Domegan; Jennifer Kieran
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-12-07       Impact factor: 3.267

4.  A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK.

Authors:  Lee Moore; Vanessa Remy; Monique Martin; Maud Beillat; Alistair McGuire
Journal:  Cost Eff Resour Alloc       Date:  2010-04-30

5.  Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands.

Authors:  Alies van Lier; Albert Jan van Hoek; Wim Opstelten; Hein J Boot; Hester E de Melker
Journal:  BMC Health Serv Res       Date:  2010-08-13       Impact factor: 2.655

6.  Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review.

Authors:  Edward T Chiyaka; Van T Nghiem; Lu Zhang; Abhishek Deshpande; Patricia Dolan Mullen; Phuc Le
Journal:  Pharmacoeconomics       Date:  2019-02       Impact factor: 4.558

7.  Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community.

Authors:  Bernhard Ultsch; Oliver Damm; Philippe Beutels; Joke Bilcke; Bernd Brüggenjürgen; Andreas Gerber-Grote; Wolfgang Greiner; Germaine Hanquet; Raymond Hutubessy; Mark Jit; Mirjam Knol; Rüdiger von Kries; Alexander Kuhlmann; Daniel Levy-Bruhl; Matthias Perleth; Maarten Postma; Heini Salo; Uwe Siebert; Jürgen Wasem; Ole Wichmann
Journal:  Pharmacoeconomics       Date:  2016-03       Impact factor: 4.981

8.  A Cost-effectiveness Analysis of an Adjuvanted Subunit Vaccine for the Prevention of Herpes Zoster and Post-herpetic Neuralgia.

Authors:  Christopher F Carpenter; Annas Aljassem; Jerry Stassinopoulos; Giovanni Pisacreta; David Hutton
Journal:  Open Forum Infect Dis       Date:  2019-05-08       Impact factor: 3.835

Review 9.  Vaccination against herpes zoster in developed countries: state of the evidence.

Authors:  Mélanie Drolet; Michael N Oxman; Myron J Levin; Kenneth E Schmader; Robert W Johnson; David Patrick; James A Mansi; Marc Brisson
Journal:  Hum Vaccin Immunother       Date:  2013-01-16       Impact factor: 3.452
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.